Co-Founder Atrility Medical Pete Lukszys is an educator, entrepreneur, and supply chain leader. Pete is co-founder and senior advisor of Atrility Medical, a UW-Madison spin-off that developed a product now used in pediatric ICUs to more rapidly and accurately identify arrhythmias after heart surgery. He served as founding CEO from formation of the company through FDA approval, manufacturing, launch and first…

Co-Founder & CEO MarPam Pharma Dr. Athanasiou is a proven leader in directing a range of cutting-edge research projects and advancing their outcomes toward clinical application. Dr. Athanasiou is a seasoned corporate pharma/biotech executive, having led interdisciplinary teams for the development of therapeutics and diagnostics. Her successes include the development of an FDA-approved drug, Vybrid…

President and CEO Estrigenix Therapeutics, Inc. Over a 38-year academic career at Marquette University, Dr. William Donaldson has exemplified the teacher-scholar model. He and his co-workers have published over 120 research articles and have been awarded more than $2.25 million in external funding to support his academic research. He is the recipient of the 1995…

Director of Research and Development Retham Technologies Curtis Jones received his Bachelor of Science in Chemistry from the University of Wisconsin-Milwaukee in 2012. He has been involved in research focused on the diagnosis, treatment, and pathophysiology of heparin-induced thrombocytopenia, an adverse reaction to heparin treatment, from 2012-2019 while at the BloodCenter of Wisconsin. In 2019,…